Cytiva, a Danaher company and a leader in the life sciences industry, has signed a FlexFactory™ contract with Yosh...
Japan-based Fujifilm Corporation has announced its investment in Valanx Biotech, an Austrian biotechnology company with ...
Fujitsu Japan Limited and Teikyo University Hospital announced the start of a joint proof of concept aimed at strengthen...
Eli Lilly Japan K.K. has decided to invest 20 billion yen in its Seishin Plant (Kobe City, Hyogo Prefecture), the only m...
PsiQuantum has signed a collaborative research agreement with the National Cancer Center Japan, a leading cancer treatme...
Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with Cyto-Fa...
Switzerland-based Curatis Holding AG and Neupharma, a Japanese pharmaceutical company specialising in oncology, immunolo...
Precision for Medicine, a global leader in biomarker-driven clinical research and development, has announced the opening...
Pfizer Japan Inc., and ASKA Pharmaceutical have announced that they will begin co-promotion of the Respiratory Syncytial...
Japan-based Fujitsu and DT-Axis have announced the commencement of a collaboration aimed at advancing digital health. Th...
Japan-based Reprocell has announced the launch of its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Ban...
PHC Corporation’s Biomedical Division, a global provider of laboratory sample storage and cell cultivation solutio...
Aicuris Anti-infective Cures AG has entered into a definitive agreement under which Japan's Asahi Kasei, through it...
US-based Sarepta Therapeutics, Inc. has announced the commercial launch of ELEVIDYS (delandistrogene moxeparvovec) in Ja...
Japan-based Astellas Pharma and US-based startup Vir Biotechnology have entered into a global strategic collaboration to...
Japan-based Shimadzu Corporation has invested in A-wave Inc., a startup originating from The University of Osaka, throug...
US-based BostonGene, the developer of the leading AI foundation model for tumour and immune biology, has announced ...
Clinigen, a global leader in accelerating patient access to critical medicines, obtained the world's first prescription ...
Japan-headquartered Nxera Pharma has entered into a license agreement with a newly established independent company (NewC...
Galderma has announced the launch of Restylane Defyne and Restylane Refyne: the first Optimal Balance Technology (OBT)â...
Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial in...
Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations gl...
South Korea-based startup Sky Labs Inc. has entered into an exclusive distribution agreement with Otsuka Pharmaceut...
Budapest-based Gedeon Richter Plc. and Japan's Fuji Pharma Co. have announced the expansion and further strengthening of...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.39 b...
